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Background: Adherent-invasive Escherichia coli (AIEC) have been implicated in the ethiopathogenesis of Crohn’s
disease (CD). In this study, we analyzed a collection of intestinal mucosa-associated E. coli isolates, presenting AIEC
phenotypes, isolated from biopsies of CD pediatric patients and non-inflammatory bowel diseases (IBD) controls, in
order to investigate their genetic and phenotypic pathogenic features.
Results: A total of 616 E. coli isolates from biopsies of four pediatric CD patients and of four non-IBD controls were
collected and individually analyzed. For AIEC identification, adherent isolates were assayed for invasiveness, and the
capacity of the adhesive-invasive isolates to survive and replicate intracellularly was determined over macrophages
J774. In this way we identified 36 AIEC-like isolates. Interestingly, their relative abundance was significantly higher in
CD patients (10%; 31/308) than in non-IBD controls (1%; 5/308) (χ2 = 38.96 p < 0.001). Furthermore pulsed field gel
electrophoresis (PFGE) and randomly amplified polymorphic DNA (RAPD) techniques were applied to analyze the
clonality of the 36 AIEC-like isolates. The results obtained allowed us to identify 27 distinct genotypes (22 from CD
patients and 5 from non-IBD controls). As for the AIEC prototype strain LF82, all 27 AIEC genotypes presented an
aggregative pattern of adherence (AA) that was inhibited by D-mannose, indicating that adhesiveness of AIEC is
likely mediated by type 1 pili. PCR analisys was used to investigate presence of virulence genes. The results indicated
that among the 27 AIEC isolates, the incidence of genes encoding virulence factors K1 (χ2 = 6.167 P = 0.013), kpsMT II
(χ2 = 6.167 P = 0.013), fyuA (χ2 = 6.167 P = 0.013), and ibeA (χ2 = 8.867 P = 0.003) was significantly higher among AIEC
strains isolated from CD patients than non-IBD controls.
Conclusions: The identification of AIEC strains in both CD and non-IBD controls, confirmed the “pathobiont” nature of
AIEC strains. The finding that AIEC-like isolates were more abundant in CD patients, indicates that a close association of
these strains with CD may also exists in pediatric patients.
Keywords: Gut microbiota, Pathobionts, Crohn’s disease, Adherent-invasive E. coli, AIEC* Correspondence: mariapia.conte@uniroma1.it
1Department of Public Health and Infectious Diseases, ‘Sapienza’ University of
Rome, Rome, Italy
Full list of author information is available at the end of the article
© 2014 Conte et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Conte et al. BMC Research Notes 2014, 7:748 Page 2 of 12
http://www.biomedcentral.com/1756-0500/7/748Background
Crohn’s disease (CD) is a disorder of the human bowel,
resulting from chronic inflammation of the gastrointes-
tinal tract. Characteristics of CD are patchy inflamma-
tion, full-thickness lesions of the intestinal wall, and
granulomas [1,2]. The etiology of this disease has not
been fully elucidated yet although it is generally accepted
that the chronic inflammation is due to deregulated im-
mune responses towards the intestinal microbiota [3,4].
The intestinal microbiota is a dynamic ecosystem that
has developed a mutualistic relationship with its host
and plays a crucial role in the development and homeo-
stasis of the immune system [5]. Recent studies have
suggested that the intestinal microbiota composition
contribute to CD pathogenesis since, compared to nor-
mal individuals, the microbiota of CD patients display
reduced diversity and altered composition [6]. Unbal-
anced composition of the intestinal microbiota has been
defined dysbiosis. A dysbiosis, localized or generalized,
has been reported in CD patients and it has been hy-
pothesized that the loss or reduction in the number of
beneficial microbes may favor colonization by potentially
aggressive pathogenic microorganisms [7,8]. Whether
dysbiosis is a consequence, a cause or a factor contribut-
ing to the insurgence, development of the disease remains
poorly understood. To date, Mycobacterium paratubercu-
losis and Escherichia coli strains have been proposed to be
associated with the onset of CD [9]. In particular, in-
creased number of mucosa associated E. coli are observed
in CD patients [10] and some genotypes, more than
others, appear to be associated with the disease [11].
Among these, mucosa-associated E. coli strains, have ac-
quired a particular relevance to their strong adhesive-
invasive properties, [12,13]. This phenotype, called E. coli
AIEC (adherent/invasive E. coli), has been proposed as a
separate pathogenetic category. Several studies conducted
mainly with strains isolated from adult CD patients, have
suggested that AIEC strains may be involved in the onset
and/or in the persistence of CD [14-16]. A detailed study
of the prototype of these strains, AIEC LF82 strain, has re-
vealed that it is able to adhere and to invade enterocytes,
and to survive and replicate within macrophages without
causing host cell death [17]. The adhesion-invasion
phenotype of LF82 strain requires the expression of type 1
pili, and of several outer membrane proteins (OMPs),
[18-20]. Furthermore, it has been shown that LF82 was
able to translocate the intestinal mucosa, thus altering its
permeability [21] and to move into deeper tissues activat-
ing an inflammatory immune response [22]. LF82 was also
shown to be able to escape autophagy both in intestinal
epithelial and dendritic cells and to interact with the M
cells of Peyer’s patches, through the expression of long
polar fimbriae [23,24]. In silico analysis of the genome of
LF82 strain indicates the presence of patho-adaptivemutations whose role in the pathogenicity of this strains
have not been fully characterized yet [25]. Furthermore, it
has been recently reported that transient colonization of
TLR5-deficient mice with AIEC strains, is sufficient to in-
duce intestinal inflammation and dysbiosis [26], reinfor-
cing the hypothesis that AIEC strains likely play a central
role in triggering chronic intestinal inflammation in sus-
ceptible host. Therefore, to precisely define the role of
these bacteria in inflammatory bowel diseases (IBD) we
need to deepen our knowledge regarding the virulence
traits of these strains, especially for those isolated from
pediatric CD patients whose available information is still
very limited. In this work we collected and characterized
616 mucosa associated E. coli isolates present in ileum bi-
opsies from four CD and four non-IBD pediatric patients
(77 E. coli isolates per ileal biopsy). The relative abundance
of isolates presenting AIEC-like properties was deter-
mined. Moreover, genotypic richness and the presence of
selected virulence genes of AIEC-like strains were charac-
terized using different molecular approaches.
Methods
Patients and bacterial strains
Six hundred-sixteen mucosa-associated independent E.
coli isolates were collected from ileum biopsies of four
pediatric patients with active CD and from four pediatric
patients with functional intestinal disorders but presenting
normal colonoscopy and histology (non-IBD controls) (age
range 2–14 years). Patients were recruited at the Pediatric
Gastroenterology Unit of the University “Sapienza” of
Rome, Italy. The study protocol was approved by the
Committee on Ethical Practice of the ‘Policlinico Um-
berto I’ hospital. Children were enrolled in the study
after written informed consent from their parents. The
diagnostic investigation was carried out according to
widely agreed international protocols. Infectious and
systemic diseases as well as structural abnormalities of
the gastrointestinal tract were excluded in all patients.
No patient had food allergy or malabsorption,and inva-
sive organisms, parasites and ova were not found in the
stools. Clostridium difficile or its toxins were not de-
tected in the stool of patients included in the study. No
patients had previous treatment with azathioprine/6-
mercaptopurine, ciclosporin or other immunosuppres-
sive agents at any time before the enrolment. The four
children with CD showed an ileocolonic involvement,
and had a disease activity score ranging to moderate to
severe. All patients did not receive any antibiotic and
corticosteroid treatments within 3 months and four
weeks, respectively, before biopsies were taken. Isola-
tion and characterization of independent E. coli isolates
from biopsy tissues have been described previously
[27]. Briefly, each biopsy sample was washed in 500 μl
of buffered physiological saline supplemented with
Conte et al. BMC Research Notes 2014, 7:748 Page 3 of 12
http://www.biomedcentral.com/1756-0500/7/7480.016% dithioerythritol to remove the mucus and then
shacked four times for 30 s in fresh physiological saline.
At this point the biopsy specimens were hypotonically
lysed by wortexing for 30 min in 500 μl of distilled
water and 100 μl of each lysed suspension was diluted
and directly plated onto Mac Conkey plates to obtain
well-isolated colonies. Biochemical identification of E.
coli isolates was carried out with the API 20E system
(bio-Merieux-Italia, Rome, Italy) and/or using the indole
assay. Seventy-seven E. coli isolates per biopsy were sub-
jected to further analysis E. coli K-12 reference strain
DH5α, E. coli EPEC 32 (O55), EIEC strain HN280 [28]
and reference E. coli AIEC LF82 strain (a kind gift of
Arlette Darfeuille-Michaud, Université d’Auvergne, France)
were used as positive or negative controls in adhesion-
invasion assays. AIEC strain LF82 and E. coli reference
strains EAEC 042, ETEC EDL 1493, DAEC C1845 and
ExPEC CFT073 (provided by Prof. P. Escobar-Paramo;
INSERM, Paris, France) were used to compare genotypic
and phenotypic characteristics of clinical isolates. Strains
were usually grown in Brain Heart Infusion (BHI, Oxoid,
Rome, Italy) or on Trypticase Soy Agar plates (TSA,
Oxoid) overnight at 37°C. Cultures were stocked at −70°C
in the presence of 15% glycerol.
Cells
Human Caco-2 (ATCC HTB-37) and HEp-2 (ATCC
CCL-23) cell lines were used to determine bacterial ad-
hesiveness and invasiveness of the E. coli isolates. HEp-2
cells were maintained in Eagle’s minimal essential
medium (E-MEM, Sigma, Italy) with 5% heat-inactivated
foetal calf serum (FCS, Euroclone Italy) supplemented
with 1% penicillin/streptomycin, in 5% CO2 atmosphere
at 37°C. Caco-2 cells were grown in Minimum Essential
Medium (MEM, Euroclone, Milan, Italy), supplemented
with 1% penicillin/streptomycin and 10% FCS and
maintained in 5% CO2 atmosphere at 37°C. The
macrophage-like J774A.1 cell line (ATCC TIB-67) was
used to determine survival and multiplication in macro-
phages. J774 macrophages were maintained in RPMI
1640 medium (Euroclone, Italy) supplemented with
10% FCS and 1% penicillin/streptomycin and 5% CO2
at 37°C.
Adhesiveness
All 616 E. coli isolates were individually tested for their
ability to adhere to cultured cells. Briefly, HEp-2 cell
monolayers were cultured on glass coverslips in 24-well
plates at a density of 1 × 105 cells/well for 24 h at 37°C.
When needed the medium was replaced 3 h before in-
fection with complete medium containing 0.5% (wt/vol)
D-mannose (Sigma-Aldrich, Italy). Bacterial cultures were
harvested in the exponential phase and suspended in cul-
ture medium with and without 0.5% D-mannose. Cellmonolayers were infected with bacterial suspensions (106
bacteria/ml; MOI = 10) and incubated at 37°C for 3 h. At
the end of incubation period infected monolayers were ex-
tensively washed with PBS, fixed in methanol, Giemsa
stained and examined with a light microscope. The ratio
between the number of adherent bacteria and the number
of plated cells was determined counting manually adher-
ent bacteria present in 10 to 20 randomly chosen micro-
scopic fields. A strain was considered to be adherent if it
was observed to adhere to more than 40% of cells. E. coli
AIEC LF82 and E. coli K-12 DH5α strains were utilized as
positive and negative controls, respectively. Adhesion as-
says were performed in three independent experiments, in
duplicate.
Invasiveness
The invasive ability of isolates was carried out only with
strains presenting an adhesive phenotype. Invasiveness
was determined using the gentamicin protection assay, as
described by Darfeuille–Michaud et al. [13]. Adhesive
strains were then used to individually infect monolayers of
HEp-2 cells cultured in 24-well plates at a density of 2 ×
105 cells/well. Bacteria were grown overnight in BHI broth
at 37°C, and HEp-2 cell monolayers were infected with
0.5 ml of bacterial suspensions (2 × 106; MOI = 10) and
incubated for 3 h at 37°C. At the end of incubation period,
cell monolayers were washed four times with PBS and
fresh medium with 100 μg/ml of gentamicin (Sigma) was
added to each well and incubation was continued for 1 h
to allow intra-cellular multiplication. Monolayers were ex-
tensively washed and lysed with a solution of 1% vol/vol
Triton X-100. Dilutions of cell lysates were plated in
TSA agar plates to determine the number of viable bac-
teria (invasive). An isolate was considered invasive
when the ratio of the number of intracellular bacteria/ini-
tial inoculum X 100 was ≥0.1% (i.e. ≥2 × 103 bacteria/well).
Survival and replication in J774 macrophages
The macrophages cell line J774 was used as model to as-
sess survival and intracellular multiplication of the ad-
herent/invasive E. coli isolates as described by Bringer
et al. [29] with minor modifications. Briefly macrophages
were seeded in 24-well tissue culture plates at a density
of 2 × 105 cells/well, grown for 24 hours at 37°C and in-
fected with adherent/invasive E. coli isolates (MOI = 10).
After 20 min of incubation at 37°C, infected monolayers
were extensively washed with PBS, and supplemented
with fresh culture medium containing 100 μg/ml of gen-
tamicin for 40 min at 37°C (1 h post infection). One
hour post infection, fresh medium containing 50 μg/ml
of gentamicin was added and infected monolayers were
further incubated for additional 24 hours. Survival and
replication of bacteria within macrophages was deter-
mined 1 and 24 h post-infection as described above.
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macrophages when the ratio between the number of
intracellular bacteria recovered after 24 h of incubation
and those recovered after 1 h (X 100) was ≥100%. Bac-
teria able to replicate within macrophages where those
that presented a ratio ≥200%. Adherent/invasive bacteria
able to survive and to multiply within macrophage were
considered AIEC strains. All assays were performed in
three independent experiments, in duplicate.
PFGE with XbaI-digested genomic DNA
The genetic relationship among AIEC isolates was exam-
ined by pulse-field electrophoresis (PFGE). Briefly, bac-
terial cultures were suspended in TN-buffer (Tris-HCl
50 mM pH 7.4, NaCl 150 mM) and embedded in 1%
agarose (LM-MP agarose, Roche, Italy) plugs. Embedded
bacteria were lysed by immerging the plugs in a solution
of Tris-HCl 200 mM pH 7.4, EDTA 0.5 M pH 8, SDS
10% proteinase K (20 mg/ml, Roche) and incubated for
24 h at 56°C. Agarose plugs were washed once with TE-
buffer (Tris-HCl 200 mM pH 7.4, EDTA 0.5 M pH 8)
and DNA was digested with 40 U/plug of XbaI overnight
at 37°C. The restriction fragments were separated by
PFGE on a CHEF-DR II system (Bio-Rad Laboratories,
Richmond, CA, USA). The pulse time ranged from 1 to
20 seconds over 21 hours (6 V/cm) at 14°C. Lambda
concatemers (New England Biolabs, Ipswich, MA) were
used as size standard. Gels were stained with ethidium
bromide and digitalized using the Kodak Digital Science
system (Kodak, Milan, Italy).
PCR-based fingerprinting using random amplified
polymorphic DNA (RAPD)
Genotyping of AIEC isolates was performed using RAPD
PCR. Bacterial DNA was purified using mericon DNA Bac-
teria Kit (Qiagen, Italy) according to the manufacturer’s in-
structions. RAPD reactions were performed using two
arbitrary primers; primer 3 (5′-d[GTAGACCCGT]-3′) and
primer 4 (5′-d[AAGAGCCCGT]-3′) [30]. Each lyophilized
primer was rehydrated in sterile distilled water prior to
use. Amplification was performed in a 25-μL reaction mix-
ture containing 1.5 mM MgCl2 (Bioline, London, UK),
0.2 mM dNTPs (Promega, Madison, WI, USA), 0.5 μM of
each primer, 1U BioTaq™ of DNA polymerase in 1X PCR
buffer (Bioline, London, UK) and 3 μL of template dsDNA
(40 ng). PCR was performed as follows: 1 cycle at 95°C for
5 min, followed by 45 cycles at 95°C for 1 min, 36°C for
1 min, and 72°C for 2 min (Mastercycler pro, Eppendorf
Germany). Ten microliters of all reactions were electro-
phoresed in 2.0% agarose gels, stained with ethidium
bromide and photographed by use a ultraviolet transillumi-
nator and a digital capture system (UVP Inc.) In order to
guarantee reproducibility of RAPD profiles, each PCR reac-
tion was performed in triplicate.PFGE and RAPD profiles analysis
The DNA banding patterns obtained by PFGE and
RAPD assays were analysed with TotalLab TL120 Trace
version 2006 (Nonlinear Dynamics) with a position tol-
erance set at 1,5%. The Dice coefficient of similarity was
calculated, and the unweighted pair group method with
arithmetic averages (UPGMA) was used for cluster ana-
lysis XLstat 7.5 (Addinsoft, USA). The similarity per-
centage cut-off to distinguish between clonally distinct
groups was set at 95%.
Adhesion phenotypes assay
The pattern of adhesiveness of our AIEC-like strains was
evaluated using HEp-2 and Caco-2 cell monolayers, localized
adherence (LA), diffuse adherence (DA) and enteroadherent-
aggregative adherence (AA) were determined for all the
AIEC genotypes by the method described by Scaletsky
et al. [31]. Monolayers were infected with bacterial sus-
pensions (106 bacteria/ml; MOI = 10) and incubated at
37°C for 3 h. Infected monolayers were examined at light
microscope after a 3-h incubation period. When needed,
bacterial cultures were harvested in the exponential phase
and suspended in culture medium with and without 0.5%
(wt/vol) D-mannose (Sigma-Aldrich, Italy).
Phylotyping
The phylogenetic group of all E. coli AIEC genotypes
was assayed by a multiplex PCR protocol [32]. The
oligonucleotide primers were designed to amplify the E.
coli associated genes chuA, yjaA and TspE4C2. Phylo-
genetic clustering was made on the basis of the results
of amplification. Namely group A was chuA–, yjaA +/-,
TspE4C2–, group B1 chuA–, yjaA+/–, TspE4C2+, group
B2 chuA+, yjaA+, TspE4C2+/–, group D chuA+, yjaA–,
TspE4C2+/–. Amplifications were carried out in 25 μl
reaction mixtures composed of 1X PCR reaction buffer
(Biolabs Inc.), 50 ng/μl of template DNA, 0.2 mM of
dNTPs (Biolabs Inc.), 0.5 μM of primers (Sigma), 1.25 U
Taq DNA polymerase (Biolabs Inc.). Amplification was
carried out for 30 cycles each consisting of a denaturing
step of 5 min at 95°C, followed by an annealing step of
30 s at 56°C and an extension step of 5 min at 72°C. The
amplification products were separated by electrophoresis
in 2.0% agarose gels, in 45 mM Tris-borate, 1 mM
EDTA buffer (pH = 8.0) containing ethidium bromide at
0.5 μg/ml at a constant voltage of 5 V/cm. Gels were
photographed under transillumination using a digital
camera (UVP Inc.) Amplification was performed in trip-
licate. The size of amplicons was determined by com-
parison with a 100-bp DNA ladder (Biolabs inc.).
Virulence genotyping by PCR
All the AIEC genotypes were assayed for selected viru-
lence and fimbrial adhesin genes known to be associated
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propriate primers [see Table 1]. Whole DNA bacterial
extracts were prepared using Qiagen DNA extraction kit
(Qiagen, Italy). E. coli strains known to encode the
assayed virulence traits were included as controls. Am-
plifications were carried out for 30 cycles in 25 μl in 1X
reaction buffer (Euroclone). Each reaction mixture con-
tained 50 ng/μl of each of template DNA, 1.5 mM
MgCl2, 0.2 mM of dNTPs (Biolabs Inc.), 0.5 μM of each
primer pairs, 1.25 U of Taq DNA polymerase (Euroclone).
For some virulence genes, namely gafD, cvaC, focG, traT
and papG allele II; sfa/focDE, iutA, papG allele III) the
multiplex PCR amplification was carried out in a total vol-
ume of 50 μl, using 5 μl of whole bacterial DNA extracts
as templates. The amplification products were separated
by electrophoresis in 2.0% agarose gels, as described above
and stained with ethidium bromide. Gels were photo-
graphed using a digital camera (UVP Inc.) Amplification
was performed in triplicate. The size of amplicons was
determined by comparison with a 100-bp DNA ladder
(Biolabs Inc.).
Statistical methods
The differences in the distribution of phylogroups of
AIEC strains, between the two populations of subjects
studied, were calculated using the χ2 test with Yates’
continuity correction. For Dice similarity index a bilat-
eral Mann-Whitney U-test was utilized to compare pa-
tients and controls. In both cases, a P value ≤0.05 was
considered statistically significant.
Results
High abundance of adherent E. coli isolates from CD
patients
Six-hundred sixteen independent E. coli isolates were
collected from ileal mucosa biopsies from four pediatric
CD patients and from four non-IBD controls. Isolates
were assayed for their ability to adhere to HEp-2 and
Caco-2 cell monolayers (as described in Materials and
Methods) and a total of 226 adherent E. coli isolates
were detected. The relative abundance of adhesive iso-
lates was significantly higher among isolates from CD
patients than non-IBD controls: 63% (161/255) vs 23%
(65/273) (χ2 = 81.69 P < 0.001), respectively. We could
not determine the adhesive ability of 88 isolates (53 E.
coli isolates from CD patients, and of 35 from non-IBD
controls) since they were highly cytotoxic when chal-
lenged with tissue culture (detachment and lysis of cell
monolayers was observed 3 h post infection) (data not
shown). Analysis of these 88 isolates revealed that all
produced higher levels of hemolysin, and the release of
hemolysin may likely account for the high cytotoxic ac-
tivity of these isolates [34]. These strains were not used
for further analysis.Invasive E. coli isolates were able to replicate within
macrophages
Invasiveness of the 226 adherent E. coli isolates was
tested by the gentamicin protection assay using HEp-2
cell monolayers [13]. At the end of the gentamicin treat-
ment, infected cell monolayers were extensively washed,
lysed, and the number of intracellular bacteria deter-
mined for each isolate (see Materials and methods for
details). Isolates were considered invasive when the
CFUs of each invasive bacteria was superior or equal to
0.1% of the number of bacteria used to infect cell
monolayers (MOI = 10). Reference E. coli K-12 strain
DH5α and reference AIEC strain LF82 were used an
non-invasive and invasive controls, respectively. Under
our experimental conditions DH5α presented an inva-
sive score of 0.0007% ±0.0005 while LF82 a score of
0.95% ±0.3 in respect of the initial bacterial inoculum
(Table 2). Of the 226 adhesive isolates, 36 were also in-
vasive (invasive score ranged from 0.40% ±0.11% to
0.88% ±0.27%) and of these 31 isolates were from three
of the four CD patients and 5 from two of the four
non-IBD controls. The relative abundance (% AIEC iso-
lates/total E. coli isolates) was significantly higher among
isolates from CD patients (31/308; 10.06%) than in non-
IBD controls (5/308; 1.62%) (χ2 = 18.43 p < 0.0001). Fur-
thermore, the relative abundance (% AIEC isolates/total E.
coli isolates for each patient) was 14/77 (18,18%), 9/77
(11,68%), 8/77 (10,38%), 0/77 (0%) in CD1,CD2,CD3 and
CD4 respectively (mean ± SD; 10,06 ± 7,52) and 4/77
(5,19%), 1/77 (1,29%), 0/77 (0%), 0/77 (0%) in controls 1,2,3
and 4 respectively (mean ± SD; 1,62 ± 2,45).
To assess whether the 36 adhesive-invasive isolates were
putative AIEC-like isolates, they were further assayed for
the ability to survive and multiply within macrophages. The
number of bacteria surviving the gentamicin treatment was
evaluated at 1 and 24 h post-infection. As expected, when
challenged with J774 macrophages, the non-invasive K-12
DH5α strain was rapidly eliminated, while LF82 retained its
ability to survive and multiply within macrophages. Re-
markably, all the 36 adherent-invasive E. coli isolates, were
able to survive and multiply within J774 macrophages
(Table 3). This finding clearly indicated that they may well
be considered AIEC-like isolates [17].
Genotypic variants among AIEC isolates
PFGE and RAPD fingerprinting analysis was conducted
in order to genotypically characterize the 36 AIEC-like
isolates and a dendrogram was constructed (Figure 1).
Using this approach, we detected 27 different genotypes
among the 36 AIEC-like isolates (22 were from CD pa-
tients and 5 from non-IBD controls). Genotypes belong-
ing to the same patient tended to cluster. Six to 10
genetic variants (mean ± SD; 7.3% ±2.3%) were detected
among the 22 AIEC-like strains isolated from CD
Table 1 Primers used for PCR analysis of known virulence genes of extra-intestinal pathogenic E. coli
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Table 1 Primers used for PCR analysis of known virulence genes of extra-intestinal pathogenic E. coli (Continued)
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from AIEC-like strains isolated from non-IBD controls.
Although the differences in genotypic richness are not sta-
tistically significant, because of the small number of pa-
tients enrolled in this study, these results may suggest a
higher diversity among AIEC strains isolated from CD pa-
tients compared to those isolated from non-IBD controls.
The similarity level among the 27 genotypes, computed by
calculating the Dice index, showed a statistically signifi-
cant difference (P <0.0001) between intra-individual
similarity (88.9% ±8.9%) and inter-individual similarity
(52.1% ±8.0%) (Figure 2). Due to the small number of
patients enrolled in this study these differences cannot
be considered significant although they are in agreement
with previous findings suggesting a higher diversity among
AIEC strains isolated from CD patients. Further study is
surely needed to clarify this point.
All the AIEC-like strains show an aggregative (AA) pattern
of adherence
The pattern of adherence of the 27 AIEC-like strains
was determined using HEp-2 as well as Caco-2 cellTable 2 HEp-2 invasiveness of the 36 AIEC isolated from
patients with CD (CD1-4) and from non-IBD controls
(Control 1-4)
Sample origin N of invasive strains a(%) Average invasion level
CD1 14 0.50 ± 0.15
CD2 9 0.40 ± 0.11
CD3 8 0.88 ± 0.27
CD4 0 --
Control 1 4 0.67 ± 0.10
Control 2 1 0.52 ± 0.15
Control 3 0 --
Control 4 0 --
Reference strains E. coli LF82 0.95 ± 0.30
E. coli DH5α 0.007 ± 0.005
aValues represent the mean percentages ± standard deviations of the means
of internalised bacteria and are expressed as the ratio of intracellular CFU/number
of bacteria used to infect cell monolayers X 100. Data represent mean and
standard errors of three independent experiments, in duplicate.
--, not determined.monolayers. Remarkably, as AIEC strain LF82, all the 27
AIEC-like strains presented an aggregative pattern of ad-
herence (AA) (Figure 3) that was inhibited by co-culturing
bacteria and both type of epithelial cells with D-mannose
(data not shown). These data are in agreement with previ-
ous work indicating that expression of type 1 pili is neces-
sary for AIEC adhesiveness [19,35].
Phylogenetic grouping and virulence genetic markers of
the AIEC-like isolates
The phylogenetic background of the 27 AIEC genotypes
was examined by PCR grouping analysis, as previously
described [32]. The 22 AIEC-like genotypes isolated
from CD patients were phylogenetically classified as fol-
lows: 40.9% (9/22) belonged to group A, 31.8% (7/22)
belonged to group D, while only 18.2% (4/22) and 9.1%
(2/22) belonged to groups B1 and B2, respectively. Of
the five AIEC strains isolated from the non-IBD con-
trols, 80% (4/5) belonged to group A and 20% (1/5) to
group B2. Although it has previously reported that the
B2 and D phylogroups were the most prevalent among
AIEC isolates [16,36], our result did not show significant
differences in phylogroup predominance and in phy-
logroups distribution in IBD compared to controls. With
the exception of fimH that was detected in all the 27
AIEC genotypes, significant differences in the presenceTable 3 Thirty-six adherent/invasive E. coli isolates were
able to persist and to replicate within J774 macrophages
Sample origin N of isolates aPercentage of survival/replication
in J744 macrophages
CD1 14 403 ± 102
CD2 9 638 ± 113
CD3 8 417 ± 133
Control 1 4 376 ± 67
Control 2 1 340 ± 110
Controls strains E. coli LF82 580 ± 120
E. coli DH5α 7.3 ± 4.0
aPercentage of intracellular bacteria at 24 hours post infection relative to the
number of bacteria after 1 h of gentamicin treatment, defined as 100%. CD1-3,
CD patients; Control 1-2; non-IBD patients. Data represent mean and standard
errors of three independent experiments made in duplicate.
Figure 1 Genetic variability among the 36 AIEC isolates from CD patients CD1, CD2 and CD3, and from non-IBD controls Control-1 and
Control-2. Consensus UPGMA dendrogram, generated on Dice coefficients of XbaI PFGE and RAPD-PCR combined profiles (similarity cut-off level
95%) identified 27 genetic variants (22 from CD patients and 5 for controls). Genotypes of AIEC strains isolated from the same patient tended to cluster.
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types isolated from CD patients and the non-IBD con-
trols (Table 4). Furthermore we found that virulence
gene profiles were more similar in genotypes coming
from the same patient being the intra-individual simi-
larity (89,3% ±12,2%) statistically different from. inter-
individual one (53,0% ±28,1%) (p < 0,0001).Discussion
In this work, a large number of E. coli isolates obtained
from ileal mucosa biopsies from four pediatric CD pa-
tients and from four non-IBD controls (77 isolates per
biopsy, for a total of 616 independent isolates) were
characterized. Isolates were analyzed to evaluate the
presence and the abundance of AIEC strains. The ability
Figure 2 Similarity analysis between AIEC genotypes isolated
from CD patients and non-IBD controls. Percentage values were
based on Dice similarity index. A P value ≤0.05 was considered
statistically significant.
Figure 3 Adhesion phenotypes assay. Phase contrast fields showing Hep
strains isolated in this work (PP45 and DF6) and with reference AIEC LF82 stra
Magnification, 1000 X.
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vive and multiply within macrophages (typical AIEC
characteristics) were detected for 36 E. coli isolates
(AIEC-like strains). We noticed a significant higher rela-
tive abundance of AIEC-like isolates among biopsies of
CD patients (31 isolates vs five isolates from non-IBD
controls), supporting previous findings indicating a close
association of AIEC strains with CD patients intestinal
mucosa [16,37]. Combined RAPD and PFGE fingerprints
analysis, conducted on the 36 AIEC-like isolates, evi-
denced 27 different genotypes, each of which appeared
to be unique for each patient. Indeed, patient CD1 har-
boured up to 10 distinct AIEC genotypes while patients
CD2 and CD3 both harboured 6 distinct genotypes,
while four and one distinct genotypes were found for
AIEC strains isolated from Control 1 and 2, respectively.
Furthermore, the dendogram, shown in Figure 1, also in-
dicates that AIEC strains isolated from the same patients
are closely related. Alike reference AIEC LF82 strain, all
the 27 AIEC genotypes presented an AA pattern of ad-
herence on HEp-2 cells. This result, led us to speculate
that this pattern could favor the intestinal colonization
and persistence within the inflamed intestinal mucosa of
CD, at least in pediatric CD patients [16,34].
In contrast with studies regarding adult CD patients
which reported phylogroup B2 as the predominant one
[16], phylogroup B2 was not predominant among our-2 and Caco-2 cell monolayers infected with two representative AIEC
in. All 27 AIEC strains showed an aggregative (AA) patterns of adherence.
Table 4 Prevalence of virulence genes, identified for each strain by PCR, in the 22 AIEC strains in CD and in the 5
non-IBD pediatric patients
Virulence Factors % of virulence genes in AIEC isolates
from CD patients (n = 22)
% of virulence genes in
non-IBD controls (n = 5)
aP value
Adhesins papA 0,00% 0,00% --
papC 0,00% 0,00% --
papEF 0,00% 0,00% --
papG 0,00% 0,00% --
papG allele II 13.63% 0,00% NS
papG allele III 0,00% 0,00% --
papG allele II e III 0,00% 0,00% --
sfa/focDE 0,00% 0,00% --
focG 0,00% 0,00% --
fimH 100.00% 100.00% NS
Afa/DraBC, 0,00% 0,00% --
nfaE 0,00% 0,00% --
gafD 0,00% 0,00% --
Capsule K1 72.72% 0,00% 0.013
K5 4.54% 0,00% NS
kpsMT II 72.72% 0,00% 0.013
kpsMT III 0,00% 0,00% --
rfc 0,00% 0,00% --
Siderophores fyuA 72.72% 0,00% 0.013
iutA 0,00% 0,00% --
Toxins cnf1 0,00% 0,00% --
cvaC 0,00% 0,00% --
hlyA 0,00% 0,00% --
Invasin ibeA 81.81% 0,00% 0.001
Pathogenic island PAI 0.00% 0,00% --
Resistance to serum traT 54.54% 0,00% NS
Transcriptional Activator gene of
aggregative adhesion fimbriae
aggR 4,54% 0,00% NS
CVD432 gene probe sequence of the
plasmid of aggregative adhesion
pAA (CVD432) 0,00% 0,00% --
aNS, not significative.
--, not determined.
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patients examined, we did not detect any significant phy-
logroup predominance or differences in phylogroup dis-
tribution. Nevertheless, we have previously reported [38]
a very low proportion of B2 strains in AIEC strains of
pediatric origin and isolated in Italy, suggesting that age
and country of provenience may well be the cause of this
discrepancy. With the exception of fimH, PCR-based
identification of virulence genes known to be present in
extra-intestinal pathogenic E. coli, indicated that only
AIEC-like strains isolated from CD patients were posi-
tive for the presence of genes involved in the synthesisof capsular material (K1, K5 and kpsMT II), in the pro-
duction of siderophores (fyuA), invasiveness (ibeA) and
resistance to serum (traT). No CD-associated AIEC iso-
lates was found positive for cnf1. Again, these results are
in contrast with those reported by Martinez-Medina
et al., [16] who found that the virulence gene content of
mucosa-associated AIEC strains isolated from adult CD
patients was similar to healthy controls. The finding that
we detected virulence genes only in AIEC-like strains
isolated from CD patients may be due to the small num-
ber of patients enrolled in this study or that by the use
of pediatric patients.
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In conclusion, the AIEC-like abundance in CD patients
and the presence of virulence genes only in CD patients
further support the hypothesis that this pathovar may
play an etiologic role in the insurgence and/or in the
persistence in CD. These results are further supported
by the recent findings indicating that colonization of the
intestinal mucosa by AIEC strains, may initiate chronic
inflammation of susceptible hosts by altering the gut
microbiota [23]. Moreover, it has been recently reported
a higher incidence of IBD in patients feed with fat-rich
Western diet. It has been suggested that a fat-rich diet
may induce changes in the composition of intestinal
microbiota that, in turn, may influence the colonization
and persistence of AIEC strains in genetically susceptible
hosts [39]. These findings open up new scenarios ad-
dressed at the development of new strategies for the pre-
vention and control of IBD not only based at eliminating
AIEC strains from the inflamed intestinal mucosa but
also throughout calibrated nutritional interventions.
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